25 July 2019
As part of the Board’s normal succession planning the Board is pleased to announce the appointment of Pam Cheng as an independent non-executive Director. The appointment will take effect from 1 March 2020. On joining the Board Pam will become a member of the Nomination & Governance, Audit & Risk and Remuneration Committees. Biographic details are set out below.
Smiths Chairman Sir George Buckley said:
“I am delighted that Pam has agreed to join the Smiths Board.
Pam’s experience in the areas of manufacturing, supply chain and technology gained with large global businesses in strategically important regions for Smiths will further strengthen the Board’s discussions on embedding world class operations.”
Biographic information:
Pam Cheng, Executive Vice-President, Operations and Information Technology, joined AstraZeneca in June 2015 after having spent 18 years in Global Manufacturing, Supply Chain and Commercial roles at Merck/MSD. Pam Cheng was President of MSD China, responsible for MSD’s entire business in China prior to joining AstraZeneca. She was the Head of Global Supply Chain Management & Logistics for Merck from 2006 to 2011 and led the transformation of Merck supply chains across the global supply network. Prior to joining Merck, she held various engineering and project management positions at Universal Oil Products, Union Carbide Corporation and GAF Chemicals. Pam is also an independent non-executive Director of the US listed company Codexis Inc. Pam holds Bachelor’s and Master’s degrees in chemical engineering from Stevens Institute of Technology in New Jersey and an MBA in marketing from Pace University in New York.
There is no further information required to be disclosed pursuant to LR 9.6.13.
Enquiries
Investor enquiries
Jemma Spalton, Smiths Group
+44 (0)20 7004 1637
+44 (0)78 6739 0350
jemma.spalton@smiths.com
Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386
marion.lebot@smiths.com
Media enquiries
Deborah Scott, FTI Consulting
+44 (0)20 3727 1459
+44 (0)797 953 7449
smiths@fticonsulting.com
Alex Le May, FTI Consulting
+44 (0)20 3727 1308
+44 (0)7702 443 312
smiths@fticonsulting.com
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group
Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit www.smiths.com.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths Group plc – Q1 Trading Update
Find out more
Smiths Detection supplies industry-leading 3D X-ray scanners to Kansai International Airport
Passengers passing through Osaka’s busiest airport will soon be able to leave liquids and electronics in bags.
Find out more
Smiths Detection receives key certification for its AI-powered threat detection technology
AI-empowered technology identifies a wide range of airport threats and meets strict EU and Dutch requirements, setting an industry benchmark
Find out more
